GenoMed (OTCPK: GMED), a Next Generation Disease Management company that uses genomics to solve diseases in humans and animals, has announced that the fourth horse in its expanded trial for West Nile virus encephalitis is recovering nicely one week after starting GenoMed's treatment.

A week ago, a horse owner in Seguin, Texas telephoned GenoMed to say that her horse, named Seminole Wind, was dying. Despite West Nile virus serum, steroids, and Benamine, the horse could no longer stand, or even blink when its eye was touched.

Within 2 hours of the first dose of GenoMed's treatment, the horse got to his feet and began drinking and eating, but went down again 24 hours later. Since then, he's been slowly getting stronger, and staying on his feet longer.

West Nile virus encephalitis affects horses more severely than people, and the odds of recovery are slimmer.

Said Dr. Moskowitz, GenoMed's CEO and Chief Medical Officer, "After an initial response to our treatment, this horse relapsed. We saw this with our previous horse, whose treatment was stopped. But this horse's owner persevered. Seminole Wind seemed to get slightly better after each dose of the medication we use, only to fall back. He slept a lot. This is our first horse to recover after being so sick. Normally, going down means death within a couple of days for horses."

Added Dr. Moskowitz, "This past week has been tough for the owner, who lavished her horse with TLC. We may try a stronger medication next time."

Dr. Moskowitz concluded, "Seminole Wind showed that our approach to West Nile virus can be successful in even the sickest horse. Even more exciting for me is the possibility that our approach could work for most viruses, including avian influenza or bird flu, in most animals. With each clinical case, we learn more."

Early treatment of WNV encephalitis has yielded the best results, so public awareness of GenoMed's treatment is important. A small case series involving the company's first 8 patients was published in a peer-reviewed medical journal in 2004.


About GenoMed

The protocol for West Nile virus is available for free from GenoMed's website, genomed, as is GenoMed's protocol for avian influenza ("bird flu"). Horse owners are encouraged to contact Dr. Moskowitz directly (see contact information) to discuss drugs and dosing.

Safe Harbor Statement

This press release contains forward looking statements, including those statements pertaining to GenoMed, Inc.'s (the Company's) treatments. The words or phrases "ought to," "should," "could," "may," or similar expressions are intended to identify "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ materially from those projected in the forward looking statements as a result of a number of risks and uncertainties, including but not limited to our research and development being subject to scientific, economic, regulatory, governmental, and technological factors. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. Unless otherwise required by applicable law, we specifically disclaim any obligation to update any forward-looking statements to reflect occurrences, developments, unanticipated events or circumstances after the date of such statement.

David W. Moskowitz MD
St. Louis, Missouri

For further information please go to:

Tag Cloud